Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(3.42)
# 2,381
Out of 4,835 analysts
10
Total ratings
90%
Success rate
20.6%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Initiated Coverage: Sell | $1,200 | $1,289.56 | -6.95% | 1 | Sep 2, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €285.00 | €232.90 | +22.37% | 1 | Apr 17, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 | $143.93 | +24.37% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $165.18 | -3.14% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $575 → $620 | $609.82 | +1.67% | 2 | Apr 17, 2026 | |
| BRKR Bruker | Reiterated: Buy | $60 | $53.43 | +12.30% | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $146.93 | +12.30% | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $408.34 | -4.49% | 1 | Oct 8, 2025 |
Mettler-Toledo International
Sep 2, 2026
Initiated Coverage: Sell
Price Target: $1,200
Current: $1,289.56
Upside: -6.95%
Sartorius Aktiengesellschaft
Apr 17, 2026
Reiterated: Buy
Price Target: €285.00
Current: €232.90
Upside: +22.37%
Merck & Co.
Apr 17, 2026
Reiterated: Buy
Price Target: $179
Current: $143.93
Upside: +24.37%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $165.18
Upside: -3.14%
Thermo Fisher Scientific
Apr 17, 2026
Reiterated: Buy
Price Target: $575 → $620
Current: $609.82
Upside: +1.67%
Bruker
Nov 20, 2025
Reiterated: Buy
Price Target: $60
Current: $53.43
Upside: +12.30%
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $146.93
Upside: +12.30%
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $408.34
Upside: -4.49%